Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 May;44(5):322-6.
doi: 10.1136/jmg.2006.046904. Epub 2007 Jan 12.

Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy

Julie Desir  1 , Graciela Moya, Orit Reish, Nicole Van Regemorter, Hilde Deconinck, Karen L David, Françoise M Meire, Marc J Abramowicz
Affiliations

Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy

Julie Desir et al. J Med Genet. 2007 May.

Abstract

Harboyan syndrome, or corneal dystrophy and perceptive deafness (CDPD), consists of congenital corneal endothelial dystrophy and progressive perceptive deafness, and is transmitted as an autosomal recessive trait. CDPD and autosomal recessive, non-syndromic congenital hereditary endothelial corneal dystrophy (CHED2) both map at overlapping loci at 20p13, and mutations of SLC4A11 were reported recently in CHED2. A genotype study on six families with CDPD and on one family with either CHED or CDPD, from various ethnic backgrounds (in the seventh family, hearing loss could not be assessed because of the proband's young age), is reported here. Novel SLC4A11 mutations were found in all patients. Why some mutations cause hearing loss in addition to corneal dystrophy is presently unclear. These findings extend the implication of the SLC4A11 borate transporter beyond corneal dystrophy to perceptive deafness.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Maumenee A E. Congenital hereditary corneal dystrophy. Am J Ophthalmol 1960501114–1124. - PubMed
    1. Kirkness C M, McCartney A, Rice N S C, Garner A, Steele A D M. Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology. Br J Ophthal 198771130–144. - PMC - PubMed
    1. Hand C K, Harmon D L, Kennedy S M, FitzSimon J S, Collum L M, Parfrey N A. Localization of the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2) to chromosome 20 by homozygosity mapping. Genomics 1999611–4. - PubMed
    1. Mohamed M D, McKibbin M, Jafri H, Rasheed Y, Woods C G, Inglehearn C F. A new pedigree with recessive mapping to CHED2 locus on 20p13. Br J Ophthalmol 200185758–759. - PMC - PubMed
    1. Vithana E N, Morgan P, Sundaresan P, Ebenezer N D, Tan D T H, Mohamed M D, Anand S, Khine K O, Venkataraman D, Yong V H K, Salto‐Tellez M, Venkatraman A, Guo K, Hemadevi B, Srinivasan M, Prajna V, Khine M, Casey J R, Inglehearn C F, Aung T. Mutations in sodium‐borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet 200638755–757. - PubMed

MeSH terms